Completed OBSERVATIONAL NCT03388086

Efficacy of Two Onabotulinum Toxin Doses

Comparing the Efficacy of Two Doses of Onabotulinum Toxin for the Treatment of Neurogenic Detrusor Overactivity - a Retrospective Cohort Study

Sponsor: Swiss Paraplegic Research, Nottwil

Conditions Neurogenic Bladder Overactive Detrusor

Interventions Injection of Onabotulinum toxin

Updated 10 times since 2018 Last updated: Aug 5, 2019 Started: Feb 1, 2018 Primary completion: Apr 30, 2019 Completion: Jul 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Neurogenic Bladder and Overactive Detrusor and is currently completed. Swiss Paraplegic Research, Nottwil leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Nov 2023 — Jul 2024 [monthly]

Completed
Jan 2021 — Nov 2023 [monthly]

Completed
Sep 2019 — Jan 2021 [monthly]

Completed

Status: Enrolling By Invitation → Completed

▶ Show 5 earlier versions

Jul 2019 — Sep 2019 [monthly]

Enrolling By Invitation
Mar 2019 — Jul 2019 [monthly]

Enrolling By Invitation
Jun 2018 — Mar 2019 [monthly]

Enrolling By Invitation
Apr 2018 — Jun 2018 [monthly]

Enrolling By Invitation

Status: Not Yet Recruiting → Enrolling By Invitation · Phase: NA → None
Jan 2018 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Swiss Paraplegic Research, Nottwil

Data source: Swiss Paraplegic Research, Nottwil

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nottwil, Switzerland